Oral or intravenous administration of azide‐modified phage nanoparticles to eradicate specific pathobiont significantly counteract the chemoresistance induced by Fn and potentiate the activity of folinic acid‐5‐FU‐irinotecan chemotherapy in mouse models of CRC [10]. This evidence concerns the gene FN1 and colorectal carcinoma.